H2020

BETA3_LVH

A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

Programme: Horizon 2020
Started: 1 May 2015
Ends: 31 Aug 2022
Duration: 88 months
Total cost: EUR 5,425,113
EU contribution: EUR 5,425,113
Participants: 20 from 8 countries
Topic: H2020_PHC-13-2014
Grant agreement: 634559

Coordinated by Universite Catholique de Louvain (BEBelgium).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
Organisation	Country	Role	EU contribution	Recognised by
Universite Catholique de Louvain	BEBelgium	Coordinator	EUR 769,755	known name (0.95)
Cliniques Universitaires Saint-Luc Asbl	BEBelgium	Third party	Not stated	VAT number (0.97)
Charite - Universitaetsmedizin Berlin	DEGermany	Participant	EUR 591,824	PIC (1.00)
Kks-Netzwerk Ev -Netzwerk der Koordinierungszentren Fur Klinische Studien	DEGermany	Third party	Not stated	PIC (1.00)
Klinikum der Universitaet Zu Koeln	DEGermany	Third party	Not stated	PIC (1.00)
Universitaet Leipzig	DEGermany	Participant	EUR 1,084,832	PIC (1.00)
Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen Rechts	DEGermany	Participant	EUR 471,420	PIC (1.00)
Universitatklinikum Leipzig	DEGermany	Third party	Not stated	PIC (1.00)
Centre Hospitalier Universitaire de Nantes	FRFrance	Participant	EUR 250,563	known name (0.95)
Ecrin European Clinical Research Infrastructure Network	FRFrance	Participant	EUR 347,146	PIC (1.00)
Societe Europeenne de Cardiologie	FRFrance	Participant	EUR 142,225	PIC (1.00)
The Chancellor, Masters and Scholars of the University of Oxford	GBUnited Kingdom	Participant	EUR 384,404	PIC (1.00)
Ethniko Kai Kapodistriako Panepistimio Athinon	GRGreece	Participant	EUR 127,273	PIC (1.00)
Panepistimiako Geniko Nosokomeio Attikon	GRGreece	Third party	Not stated	PIC (1.00)
Azienda Ospedaliera Papa Giovanni XXIII	ITItaly	Participant	EUR 379,583	PIC (1.00)
Fondazione Per la Ricerca Ospedale Maggiore de Bergamo	ITItaly	Third party	Not stated	PIC (1.00)
Uniwersytet Medyczny Im Piastow Slaskich We Wroclawiu	PLPoland	Participant	EUR 654,585	known name (0.97)
Associação para Investigação e Desenvolvimento da Faculdade de Medicina	PTPortugal	Participant	EUR 221,505	PIC (1.00)
Centro Hospitalar Lisboa Norte Epe	PTPortugal	Third party	Not stated	known name (0.95)
SPRM - Sociedade Portuguesa de Ressonancia Magnetica SA	PTPortugal	Third party	Not stated	PIC (1.00)

Changes of the consortium

First seen on 18 Oct 2026 with 20 participants from 8 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on 17 Oct 2026. Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.